Efficacy of Mitragyna speciosa (Kratom) Extract for Diabetic Ulcer Healing: A Literature Review
Article Sidebar
Main Article Content
Page: 1857-1867
Abstract
Diabetic ulcers, particularly diabetic foot ulcers (DFUs), are chronic complications of diabetes mellitus characterized by persistent inflammation, oxidative stress, impaired angiogenesis, increased infection risk, and delayed tissue remodeling. Botanically derived adjuncts have gained attention because their mixed phytochemical profiles may act on several wound-healing pathways simultaneously. Mitragyna speciosa (kratom) is an alkaloid-rich Rubiaceae plant with reported anti-inflammatory, antioxidant, antimicrobial, and pro-regenerative activities. This review aimed to evaluate the current evidence on the potential role of Mitragyna speciosa extract in diabetic ulcer healing, distinguish kratom-specific evidence from broader botanical context, and identify key knowledge gaps that must be addressed before clinical translation. Methods: A PRISMA-style systematic review was conducted using an internet search engine, which returned 521 records. Records were screened against predefined population, intervention, comparator, outcome, study-design, and attribution criteria. Eight sources met the eligibility criteria and were synthesized qualitatively. Results: No clinical trial, observational study, or in vivo diabetic-wound study directly compared kratom extract with standard wound care. Kratom-specific evidence was limited to in vitro and formulation studies. The available in vitro synthesis reported suppression of tumor necrosis factor-alpha, interleukin-6, cyclooxygenase-2, 5-lipoxygenase, nitric oxide, and reactive oxygen species, as well as stimulation of cell migration and angiogenesis. A topical spray film-forming kratom formulation has been developed, but efficacy data are not yet available. Broader systematic reviews indicate that botanical adjuncts may improve DFU healing outcomes, but these reviews did not include kratom. Current evidence supports biological plausibility but does not establish comparative effectiveness. Standardized kratom formulations require in vivo validation, dose-response assessment, safety evaluation, and adequately powered randomized clinical trials before any clinical recommendation can be made.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
References
. Armstrong DG, Tan TW, Boulton AJ, Bus SA. Diabetic foot ulcers: a review. Jama. 2023 Jul 3;330(1):62-75.https://doi.org/10.1001/jama.2023.10578. DOI: https://doi.org/10.1001/jama.2023.10578
. Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. The New England Journal of Medicine 2017;376:2367-2375. https://doi.org/10.1056/NEJMra1615439. DOI: https://doi.org/10.1056/NEJMra1615439
. Ahmadian R, Bahramsoltani R, Marques AM, Rahimi R, Farzaei MH. Medicinal plants as efficacious agents for diabetic foot ulcer: a systematic review of clinical studies. Wounds 2021;33:207-218. https://doi.org/10.25270/wnds/2021.207218. DOI: https://doi.org/10.25270/wnds/2021.207218
. Deng H, Li B, Shen Q, Zhang C, Kuang L, Chen R, et al. Mechanisms of diabetic foot ulceration: a review. Journal of Diabetes 2023;15:299-312. https://doi.org/10.1111/1753-0407.13372. DOI: https://doi.org/10.1111/1753-0407.13372
. Burgess JL, Wyant WA, Abdo Abujamra B, Kirsner RS, Jozic I. Diabetic wound-healing science. Medicina 2021;57:1072. https://doi.org/10.3390/medicina57101072. DOI: https://doi.org/10.3390/medicina57101072
. Wilkinson HN, Hardman MJ. Wound healing: cellular mechanisms and pathological outcomes. Open Biology 2020;10:200223. https://doi.org/10.1098/rsob.200223. DOI: https://doi.org/10.1098/rsob.200223
. Eming SA, Martin P, Tomic-Canic M. Wound repair and regeneration: mechanisms, signaling, and translation. Science Translational Medicine 2014;6:265sr6. https://doi.org/10.1126/scitranslmed.3009337. DOI: https://doi.org/10.1126/scitranslmed.3009337
. Chen P, Campillo Vilorio N, Dhatariya K, et al. Guidelines on interventions to enhance healing of foot ulcers in persons with diabetes (IWGDF 2023 update). Diabetes/Metabolism Research and Reviews 2024;40:e3644. https://doi.org/10.1002/dmrr.3644. DOI: https://doi.org/10.1002/dmrr.3644
. Bus SA, Armstrong DG, Crews RT, Gooday C, Jarl G, Kirketerp-Moller K, et al. Guidelines on offloading foot ulcers in persons with diabetes (IWGDF 2023 update). Diabetes/Metabolism Research and Reviews 2024;40:e3647. https://doi.org/10.1002/dmrr.3647. DOI: https://doi.org/10.1002/dmrr.3647
. Novitasari PR, Nuraisyah F, Hikmawan BD, Ahmad I, Djannah SN. Spray film-forming system formulation of Mitragyna speciosa as a diabetic wound-healing agent. Journal of Advanced Pharmaceutical Technology & Research 2025;16:119-124. https://doi.org/10.4103/JAPTR.JAPTR_398_24. DOI: https://doi.org/10.4103/JAPTR.JAPTR_398_24
. Sen CK. Human wound and its burden: updated 2020 compendium of estimates. Advances in Wound Care 2021;10:281-292. https://doi.org/10.1089/wound.2021.0026. DOI: https://doi.org/10.1089/wound.2021.0026
. Mahmood BA, Youssef HA, Mohamed BA, Radwan A, Elghouneimy MA, Mohamed NA, Ahmed El Saghier EO, Elkader TM, Abd El Fattah MO, Shawky TA, El-Senosy FM. Topical Herbal Products as Adjuncts to Standard Care for the Management of Diabetic Foot Ulcers. The Natural Products Journal. 2024 Nov 4.. https://doi.org/10.2174/0122103155331492241025083322. DOI: https://doi.org/10.2174/0122103155331492241025083322
. Djuma E, Yulia, Kurnia DA. Efektivitas penggunaan terapi topical herbal pada perawatan ulkus kaki diabetik: a systematic literature review. Holistik Jurnal Kesehatan 2024;18:202-208. https://doi.org/10.33024/hjk.v18i2.281. DOI: https://doi.org/10.33024/hjk.v18i2.281
. Akbulut S, PEKCAN M. The Effects of Topical Applications of Momordica charantia Extract on Wound Healing: A Comprehensive Review Momordica charantia Ekstraktının Topikal Uygulamalarının Yara İyileşmesi Üzerindeki Etkileri: Kapsamlı Bir Derleme. Fabad Journal of Pharmaceutical Sciences. 2024;49(2):423-434. https://doi.org/10.55262/fabadeczacilik.1349346. DOI: https://doi.org/10.55262/fabadeczacilik.1349346
. Begum T, Arzmi MH, Khatib A, Uddin ABMH, Abdullah MA, Rullah K, et al. A review on Mitragyna speciosa (Rubiaceae) as a prominent medicinal plant based on ethnobotany, phytochemistry, and pharmacological activities. Natural Product Research 2025;39:1636-1652. https://doi.org/10.1080/14786419.2024.2371564. DOI: https://doi.org/10.1080/14786419.2024.2371564
. Ahmad I, Prabowo WC, Arifuddin M, Fadraersada J, Indriyanti N, Herman H, et al. Mitragyna species as pharmacological agents: from abuse to promising pharmaceutical products. Life 2022;12:193. https://doi.org/10.3390/life12020193. DOI: https://doi.org/10.3390/life12020193
. Eastlack SC, Cornett EM, Kaye AD. Kratom-pharmacology, clinical implications, and outlook: a comprehensive review. Pain and Therapy 2020;9:55-69. https://doi.org/10.1007/s40122-020-00151-x. DOI: https://doi.org/10.1007/s40122-020-00151-x
. Henningfield JE, Fant RV, Wang DW. The abuse potential of kratom according to the 8 factors of the Controlled Substances Act: implications for regulation and research. Psychopharmacology 2018;235:573-589. https://doi.org/10.1007/s00213-017-4813-4. DOI: https://doi.org/10.1007/s00213-017-4813-4
. Tuntiyasawasdikul S, Junlatat J, Tabboon P, Limpongsa E, Jaipakdee N. Mitragyna speciosa ethanolic extract: extraction, anti-inflammatory, cytotoxicity, and transdermal delivery assessments. Industrial Crops and Products 2024;208:117909. https://doi.org/10.1016/j.indcrop.2023.117909. DOI: https://doi.org/10.1016/j.indcrop.2023.117909
. Rahmawati SI, Indriani DW, Ningsih FN, Hardhiyuna M, Firdayani F, Ahmadi P, et al. Dual anti-inflammatory activities of COX-2/5-LOX driven by kratom alkaloid extracts in lipopolysaccharide-induced RAW 264.7 cells. Scientific Reports 2024;14:28993. https://doi.org/10.1038/s41598-024-79229-x. DOI: https://doi.org/10.1038/s41598-024-79229-x
. Sornsenee P, Chimplee S, Romyasamit C. Evaluation of antibacterial, antibiofilm, antioxidant, and anti-inflammatory activities of kratom leaves (Mitragyna speciosa ) fermentation supernatant containing Lactobacillus rhamnosus GG. Probiotics and Antimicrobial Proteins 2025;17:328-340. https://doi.org/10.1007/s12602-023-10142-x. DOI: https://doi.org/10.1007/s12602-023-10142-x
. Limcharoen T, Pouyfung P, Ngamdokmai N, Prasopthum A, Ahmad AR, Wisdawati W, et al. Inhibition of alpha-glucosidase and pancreatic lipase properties of Mitragyna speciosa (Korth.) Havil. (kratom) leaves. Nutrients 2022;14:3909. https://doi.org/10.3390/nu14193909. DOI: https://doi.org/10.3390/nu14193909
. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71. https://doi.org/10.1136/bmj.n71. DOI: https://doi.org/10.1136/bmj.n71
. Zhong LY, Wang JL, Bo Y, Luo N, Hao PS. Pharmaceutical preparations of Periplaneta americana for skin ulcer: a protocol for a meta-analysis of randomized controlled trials. INPLASY 2022;202250131. https://doi.org/10.37766/inplasy2022.5.0131. DOI: https://doi.org/10.37766/inplasy2022.5.0131
. Hanafi ESAF, Pramesti RA, Jazuli MAS, Rihhadatulays KNJ, Salim HM, Savitri AD. The role of Mitragyna speciosa (Korth) as an anti-inflammatory agent in wound healing in living cells. Medical and Health Science Journal 2025;9:54-62. https://doi.org/10.33086/mhsj.v9i1.7994. DOI: https://doi.org/10.33086/mhsj.v9i1.7994